Home » Interviews » Widecells Group Plc Experiencing very high demand from all continents
WideCells Group

Widecells Group Plc Experiencing very high demand from all continents

Widecells Group Plc (LON:WDC) CEO João Andrade talks to DirectorsTalk about its private placing to accelerate the roll out of its 3 main divisions. João explains the plans for Cellplan given the worldwide attention it is getting, how WideAcademy fits in with the group, talks about the new initiatives VP Alan Greenberg has developed and gives a detailed outline of newsflow that we should expect over the coming weeks and months.

WideCells Group PLC is building an integrated stem cell services company, focused on making stem cell treatments accessible and affordable. The Directors believe that the use of cord blood stem cells for transplant will drive one of the next important phases in medicine and is therefore developing market leading products in complementary, strategic areas which are designed to take advantage of substantial market opportunities in one of the fastest growing segments in the healthcare industry. With this in mind, it has created three divisions:

· CellPlan: the world’s first stem cell healthcare insurance plan with financial cover for medical treatment, travel and accommodation expenses and concierge service to manage the treatment process.

· WideCells: the Institute of Stem Cell Technology has been established and is based in the University of Manchester Innovation Centre to focus on stem cell research and regenerative medicine. WideCells also has international cryogenics divisions specialising on stem cell storage.

· WideAcademy: developing an education and training division to promote awareness of the benefits of stem cell storage across the global general practice community.

The Group has built an experienced senior management team that has been integral to the development of its growth and business to date.